On January 15, 2004, Seeberger, Peter H.; Hewitt, Michael C.; Snyder, Daniel published a patent.Formula: C16H19NO6S The title of the patent was Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycans. And the patent contained the following:
One aspect of the present invention relates to solution-phase synthesis approaches to glycosylphosphatidylinositol (GPI) I, wherein, n is 1-4; R represents independently for each occurrence H, alkyl, aryl, CH2-aryl, C(O)-alkyl, C(O)-aryl, or Si(alkyl)3; R1 and R2 are independently H, CH2-aryl, C(O)-alkyl, C(O)-aryl, Si(alkyl)3; or R1 and R2 taken together are C(CH3)2, P(O)OH, or P(O)OR5; R3 is amino, N3, or NH3X; R4 represents independently for each occurrence H, alkyl, aryl, CH2-aryl, C(O)- alkyl, C(O)-aryl, Si(alkyl)3, or P(O)(OR5)2; R5 represents independently for each occurrence H, Li+, Na+, K+, Rb+, Cs+, aryl, or an optionally substituted alkyl group; and X is a halogen, alkyl carboxylate, or aryl carboxylate. Another aspect of the present invention relates to key building blocks, and syntheses thereof, useful for GPI assembly. Yet another aspect of the invention relates to an automated method for the synthesis of GPIs and fragments thereof. The synthesis of a pseudo-hexasaccharide glycosylphosphatidylinositol has been reduced to practice, both in solution and using a combination of solution and automated solid-phase methodologies. The material made in solution was covalently attached to a protein carrier and used to vaccinate mice. Inoculated mice were substantially protected against a subsequent challenge with Plasminodium parasites. This discovery further implicates GPI as the dominant toxin in malaria infections, and lays the groundwork for future trials in human volunteers. Combinations of solution and automated solid-phase synthetic methodologies will see continued usage in this context, and are expected to lead to the rapid generation of more potent vaccines for malaria and other maladies. The experimental process involved the reaction of Ethyl 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-thio-beta-D-glucopyranoside(cas: 130539-43-4).Formula: C16H19NO6S
The Article related to glycosylphosphatidylinositol oligosaccharide glycan solid phase synthesis vaccine human, Carbohydrates: Alditols, Cyclitols, Glycerides and other aspects.Formula: C16H19NO6S
Referemce:
Indole alkaloid derivatives as building blocks of natural products from聽Bacillus thuringiensis聽and聽Bacillus velezensis聽and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles